Literature DB >> 20351353

High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.

Xiao-Feng Li1, Yuanyuan Ma, Xiaorong Sun, John L Humm, C Clifton Ling, Joseph A O'Donoghue.   

Abstract

UNLABELLED: The objective of this study was to examine (18)F-FDG uptake in microscopic tumors grown intraperitoneally in nude mice and to relate this to physiologic hypoxia and glucose transporter-1 (GLUT-1) expression.
METHODS: Human colon cancer HT29 and HCT-8 cells were injected intraperitoneally into nude mice to generate disseminated tumors of varying sizes. After overnight fasting, animals, breathing either air or carbogen (95% O(2) + 5% CO(2)), were intravenously administered (18)F-FDG together with the hypoxia marker pimonidazole and cellular proliferation marker bromodeoxyuridine 1 h before sacrifice. Hoechst 33342, a perfusion marker, was administered 1 min before sacrifice. After sacrifice, the intratumoral distribution of (18)F-FDG was assessed by digital autoradiography of frozen tissue sections. Intratumoral distribution was compared with the distributions of pimonidazole, GLUT-1 expression, bromodeoxyuridine, and Hoechst 33342 as visualized by immunofluorescent microscopy.
RESULTS: Small tumors (diameter, <1 mm) had high (18)F-FDG accumulation and were severely hypoxic, with high GLUT-1 expression. Larger tumors (diameter, 1-4 mm) generally had low (18)F-FDG accumulation and were not significantly hypoxic, with low GLUT-1 expression. Carbogen breathing significantly decreased (18)F-FDG accumulation and tumor hypoxia in microscopic tumors but had little effect on GLUT-1 expression.
CONCLUSION: There was high (18)F-FDG uptake in microscopic tumors that was spatially associated with physiologic hypoxia and high GLUT-1 expression. This enhanced uptake was abrogated by carbogen breathing, indicating that in the absence of physiologic hypoxia, high GLUT-1 expression, by itself, was insufficient to ensure high (18)F-FDG uptake.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351353      PMCID: PMC2917184          DOI: 10.2967/jnumed.109.071233

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

1.  Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.

Authors:  L Bentzen; S Keiding; M R Horsman; L Falborg; S B Hansen; J Overgaard
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

Review 2.  18F-FDG PET and PET/CT in the evaluation of cancer treatment response.

Authors:  Simona Ben-Haim; Peter Ell
Journal:  J Nucl Med       Date:  2009-01       Impact factor: 10.057

3.  Hypoxia-Induced increase in FDG uptake in MCF7 cells.

Authors:  P Burgman; J A Odonoghue; J L Humm; C C Ling
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

4.  The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.

Authors:  Miao Zhang; Xufeng Jiang; Min Zhang; Haoping Xu; Ge Zhai; Biao Li
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

5.  Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.

Authors:  Xiao-Feng Li; Xiaorong Sun; Yuanyuan Ma; Makiko Suehiro; Mutian Zhang; James Russell; John L Humm; C Clifton Ling; Joseph A O'Donoghue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-17       Impact factor: 9.236

6.  The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.

Authors:  A Waki; H Kato; R Yano; N Sadato; A Yokoyama; Y Ishii; Y Yonekura; Y Fujibayashi
Journal:  Nucl Med Biol       Date:  1998-10       Impact factor: 2.408

7.  Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

Authors:  Morten Busk; Michael R Horsman; Steen Jakobsen; Johan Bussink; Albert van der Kogel; Jens Overgaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

8.  Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.

Authors:  A C Clavo; R S Brown; R L Wahl
Journal:  J Nucl Med       Date:  1995-09       Impact factor: 10.057

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 10.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

View more
  16 in total

1.  The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG-Based Study.

Authors:  Philippe Garrigue; Aurore Bodin-Hullin; Laure Balasse; Samantha Fernandez; Wassim Essamet; Françoise Dignat-George; Karel Pacak; Benjamin Guillet; David Taïeb
Journal:  J Nucl Med       Date:  2017-06-15       Impact factor: 10.057

Review 2.  Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?

Authors:  Jianbo Li; Guojian Zhang; Xuemei Wang; Xiao-Feng Li
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

3.  The usefulness of combined diagnostic CT and (99m)Tc-octreotide somatostatin receptor SPECT/CT imaging on pulmonary nodule characterization in patients.

Authors:  Liwei Wang; Xindao Yin; Feng Wang; Jianping Gu; Lingquan Lu; Qianzhi Wu; Baozhong Shen; Xiao-Feng Li
Journal:  Cancer Biother Radiopharm       Date:  2013-10-05       Impact factor: 3.099

4.  Combined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.

Authors:  Xiao-Feng Li; Tao Huang; Huijie Jiang; Xuemei Wang; Baozhong Shen; Xiangcheng Wang; Chin K Ng; Gregory C Postel; A Cahid Civelek
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

5.  (18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings.

Authors:  Tao Huang; A Cahid Civelek; Huaiyu Zheng; Chin K Ng; Xiaoxian Duan; Junling Li; Gregory C Postel; Baozhong Shen; Xiao-Feng Li
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08

Review 6.  Targeting hypoxic tumour cells to overcome metastasis.

Authors:  Kevin L Bennewith; Shoukat Dedhar
Journal:  BMC Cancer       Date:  2011-11-30       Impact factor: 4.430

7.  Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma.

Authors:  Hongping Xia; Jianxiang Chen; Hengjun Gao; Shik Nie Kong; Amudha Deivasigamani; Ming Shi; Tian Xie; Kam M Hui
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-12       Impact factor: 9.236

8.  Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma.

Authors:  Sen-Xiang Yan; Xing-Mei Luo; Shui-Hong Zhou; Yang-Yang Bao; Jun Fan; Zhong-Jie Lu; Xin-Biao Liao; Ya-Ping Huang; Ting-Ting Wu; Qin-Ying Wang
Journal:  Int J Med Sci       Date:  2013-08-21       Impact factor: 3.738

9.  Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter-1 and hypoxia-inducible-factor-1α and the phosphoinositide 3-kinase/protein kinase B pathway.

Authors:  Kui Zhao; Shu-Ye Yang; Shui-Hong Zhou; Meng Jie Dong; Yang-Yang Bao; Hong-Tian Yao
Journal:  Oncol Lett       Date:  2014-02-12       Impact factor: 2.967

10.  (18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application.

Authors:  Xiao-Feng Li; Yang Du; Yuanyuan Ma; Gregory C Postel; A Cahid Civelek
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.